ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02133001
Brief Title: A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide

First Submitted : May 6, 2014
First Submitted that Met QC Criteria : May 6, 2014
First Posted : May 7, 2014 (Estimate)

Certification/Extension First Submitted : October 13, 2016
Certification/Extension First Submitted that Met QC Criteria : October 13, 2016
Certification/Extension First Posted : October 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 13, 2016
Last Update Posted : October 14, 2016 (Estimate)